NASDAQ:VERU
Veru Stock News
$1.27
+0.0600 (+4.96%)
At Close: Apr 26, 2024
Veru Reports Record Fiscal 2020 Fourth Quarter and Record Full-Year Financial Results
06:30am, Wednesday, 09'th Dec 2020
—FY20 Full-Year Net Revenue s and Gross Profit Achieve Historical Highs o f $4 3 M illion and $ 31 M illion , Respectively—
Preview: Veru's Earnings
10:05am, Tuesday, 08'th Dec 2020
Veru (NASDAQ:VERU) releases its next round of earnings this Wednesday, December 09. Here is Benzinga's essential guide to Veru's Q4 earnings report.
Veru to Report Fiscal 2020 Fourth-Quarter, Full-Year Financial Results, Host Conference Call on December 9th
08:30am, Monday, 23'rd Nov 2020
MIAMI, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer, t
